Tg Therapeutics (TGTX) Income from Non-Controlling Interests (2010 - 2012)
Tg Therapeutics (TGTX) posted quarterly Income from Non-Controlling Interests of -$8.1 million for Q3 2012, down 534199.07% year-over-year from N/an in Q4 2011, and down 3.17% quarter-over-quarter from -$7.8 million in Q2 2012.
Tg Therapeutics (TGTX) Income from Non-Controlling Interests (2010 - 2012) Analysis & Trends
Tg Therapeutics' Income from Non-Controlling Interests history runs 3 years deep, the most recent figure standing at -$8.1 million for Q3 2012.
- In Q3 2012, Income from Non-Controlling Interests fell 534199.07% year-over-year to -$8.1 million; the TTM figure through Sep 2013 stood at -$8.1 million (up 65.0% YoY), while the FY2012 annual figure was -$8.1 million, down 22430.3% from the prior year.
- Income from Non-Controlling Interests for Q3 2012 stood at -$8.1 million, down from -$7.8 million in the prior quarter.
- The five-year high for Income from Non-Controlling Interests was $2419.0 in Q4 2010, with the low at -$8.1 million in Q3 2012.
- The 3-year median for Income from Non-Controlling Interests is -$19592.0 (2011), against an average of -$3.3 million.
- The sharpest annual moves came in 2011 and 2012: Income from Non-Controlling Interests sank 909.92% in 2011, then sank 534199.07% in 2012.
- Tg Therapeutics' Income from Non-Controlling Interests stood at $2419.0 in 2010, then tumbled by 909.92% to -$19592.0 in 2011, then tumbled by 41079.64% to -$8.1 million in 2012.
- Business Quant data shows TGTX's Income from Non-Controlling Interests at -$8.1 million in Q3 2012, -$7.8 million in Q2 2012, and -$7.1 million in Q1 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 63.60 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Tg Therapeutics | 7.46 Bn | 6.78 Bn | 199.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2012 | -8.07 Mn |
| Jun 30, 2012 | -7.82 Mn |
| Mar 31, 2012 | -7.14 Mn |
| Dec 31, 2011 | -19,592.00 |
| Sep 30, 2011 | -1,510.00 |
| Jun 30, 2011 | -14,895.00 |
| Dec 31, 2010 | 2,419.00 |